In the presence of p21, Plk1 inhibition, along with an induction of mitotic arrest, enhances strikingly the expression of p21 and activates MAPK/Erk and PI3K/Akt pathways, which likely stabilizes p21 in the cytoplasm of treated tumor cells. This evidence concerns the gene CDKN1A and neoplasm.